Pacira Pharm Inc (PCRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2018 | 09-2018 | 06-2018 | 03-2018 | 12-2017 | |
| Sales | 95,115 | 83,448 | 84,107 | 74,607 | 79,078 |
| Cost of Goods | 23,979 | 19,065 | 20,916 | 22,885 | 21,295 |
| Gross Profit | 71,136 | 64,383 | 63,191 | 51,722 | 57,783 |
| Operating Expenses | 59,852 | 60,400 | 57,566 | 59,544 | 49,613 |
| Operating Income | 12,263 | 4,048 | 6,541 | -6,937 | 8,465 |
| Interest Expense | 5,753 | 5,642 | 5,397 | 5,157 | 5,105 |
| Other Income | 1,813 | 892 | 1,455 | 1,449 | 1,270 |
| Pre-tax Income | 8,323 | -702 | 2,599 | -10,645 | 4,630 |
| Income Tax | 38 | -62 | 35 | 35 | 35 |
| Net Income Continuous | 8,285 | -640 | 2,564 | -10,680 | 4,595 |
| Net Income | $8,285 | $-640 | $2,564 | $-10,680 | $4,595 |
| EPS Basic Total Ops | 0.21 | -0.02 | 0.06 | -0.26 | 0.13 |
| EPS Basic Continuous Ops | 0.20 | -0.02 | 0.06 | -0.26 | 0.13 |
| EPS Diluted Total Ops | 0.21 | -0.02 | 0.06 | -0.26 | 0.13 |
| EPS Diluted Continuous Ops | 0.21 | -0.02 | 0.06 | -0.26 | 0.13 |
| EBITDA(a) | $20,005 | $11,181 | $12,954 | $-671 | $15,546 |